A study by UMass Chan researchers on variations in medications used in nursing homes for patients with Alzheimer’s and other dementias found that antidementia drug use varied by geographic region, while use of antipsychotics was associated with poorer nursing home quality and patient factors.

The two published papers both started with a single question: “What regulates the immune response in C. elegans?”

Discussing the COVID-19 vaccine with vaccine-hesitant patients can be frustrating, a focus group of primary care providers reported in a recent study led by Kimberly Fisher, MD. But having the vaccine available in the clinic, as well as incorporating motivational interviewing techniques, may offer a way forward.  

UMass Chan Medical School scientists Marcus Ruscetti, PhD, and Prabhani Atukorale, PhD, have developed a new, dual immunotherapy approach that may potentially change the way clinicians treat pancreatic cancer.  

Two new donor-funded fellowships are being launched this year at UMass Chan to recruit recent postdoctoral scientists and, through intensive mentoring and resource support, foster their development as independent investigators. The fellowships align with the vision embodied in The Morningside Foundation’s transformational $175 million gift in 2021.  

Shan Lu MD, PhD, co-authored a pair of studies related to the Phase I clinical trial of a polyvalent DNA/prime-protein boost vaccine to prevent HIV, marking the latest step in a decades long quest to harness the power of DNA vaccines to address a major global health need.